Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial

Bipolar DisorderAlcohol Use Disorder (AUD)

Feasibility and acceptability of integrated psychological therapy versus treatment as usual for people with bipolar disorder and co-morbid alcohol use: A single blind randomised controlled trial

J Affect Disord.

Jones SH, Riste L, Robinson H, Holland F, Peters S, Hartwell R, Berry K, Fitzsimmons M, Wilson I, Hilton C, Long R, Bateman L, Weymouth E, Owen R, Roberts C, Barrowclough C

doi: 10.1016/j.jad.

Alcohol Use Disorder (AUD)

Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

JAMA Intern Med.

Anton RF, Latham P, Voronin K, Book S, Hoffman M, Prisciandaro J, Bristol E

doi: 10.1001/jamainternmed.

Alcohol Use Disorder (AUD)

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials

JAMA Psychiatry.

Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J, Alcohol Clinical Trials Initiative (ACTIVE) Workgroup

doi: 10.1001/jamapsychiatry.

Anxiety and Depression

Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study

JAMA Psychiatry.

Latif ZE, Šaltyte Benth J, Solli KK, Opheim A, Kunoe N, Krajci P, Sharma-Haase K, Tanum L

doi: 10.1001/jamapsychiatry.

Further Publications NeurologyFurther Publications Psychiatry

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Lancet Psychiatry.

Freeman TP, Hindocha C, Baio G, Shaban NDC, Thomas EM, Astbury D, Freeman AM, Lees R, Craft S, Morrison PD, Bloomfield MAP, O'Ryan D, Kinghorn J, Morgan CJA, Mofeez A, Curran HV

doi: 10.1016/S2215-0366(20)30290-X.

Aging and Cognitive FunctionsAnxiety and Depression

Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial

Lancet Psychiatry

Creswell C, Violato M, Fairbanks H, White E, Parkinson M, Abitabile G, Leidi A, Cooper PJ

doi: 10.1016/

Anxiety and Depression

The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial

JAMA Psychiatry.

Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Conklin LR, Boswell JF, Ametaj A, Carl JR, Boettcher HT, Cassiello-Robbins C

doi: 10.1001/

Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial

JAMA Psychiatry.

Dunn KE, Tompkins DA, Bigelow GE, Strain EC

doi: 10.1001/jamapsychiatry.

Psychosis and Schizophrenia

Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence

Front Psychiatry.

Moulin V, Baumann P, Gholamrezaee M, Alameda L, Palix J, Gasser J, Conus P

doi: 10.3389/fpsyt.2018.00294.

Related content

Feasibility and acceptability of integrated psychological therapy versus treatment as usual for people with bipolar disorder and co-morbid alcohol use: A single blind randomised controlled trial

Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials

Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial

The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial

Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial

Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence